Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study
Objectives Inflammatory bowel diseases (IBDs) and multiple sclerosis (MS) are inflammatory diseases resulting from an interplay of genetic and environmental factors. This study aims to describe the prevalence of patients diagnosed with both conditions among those receiving hospital care in England,...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e088808.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849688125992861696 |
|---|---|
| author | Kevin G Pollock Bethany Levick Faisal Sheikh Baptiste Coxam Hanna Kew Maeve Fraser Chris Rolfe Tracey Ellison |
| author_facet | Kevin G Pollock Bethany Levick Faisal Sheikh Baptiste Coxam Hanna Kew Maeve Fraser Chris Rolfe Tracey Ellison |
| author_sort | Kevin G Pollock |
| collection | DOAJ |
| description | Objectives Inflammatory bowel diseases (IBDs) and multiple sclerosis (MS) are inflammatory diseases resulting from an interplay of genetic and environmental factors. This study aims to describe the prevalence of patients diagnosed with both conditions among those receiving hospital care in England, as well as the characteristics and healthcare resource use (HCRU) of such patients.Design This study is a retrospective observational cohort study.Setting The study was conducted through secondary use of the English Hospital Episode Statistics (HES) Database. HES records care delivered by hospitals in England and associated diagnoses.Participants Patients who had a diagnosis code for either IBD or MS recorded in HES between January 2014 and May 2020 were included. Patients were classified as having each diagnosis individually or as having both diagnoses, in which case they were further categorised based on temporal occurrence.Primary and secondary outcome measures The primary outcome was the prevalence of patients with a recorded diagnosis of either IBD, MS or both during the study period. Secondary outcome measures included patient demographic and clinical characteristics, as well as HCRU in the 6 months before and after the diagnosis of interest.Results From an overall cohort of 352 698 patients, 1016 (0.3%) had both diagnoses. Among those with both, 29.8% (303) had a record of IBD first, 40.5% (411) had MS diagnosed first and 29.7% (302) had the first record of both diagnoses in the same episode. From the overall cohort, 80.9% (285 439) of patients had a single diagnosis of IBD, and 18.8% (66 243) of patients had a single diagnosis of MS.Conclusions The population with a dual diagnosis of IBD and MS is larger than previously reported and shows evidence of frequent interactions with secondary care. |
| format | Article |
| id | doaj-art-eb628f56dc5e486fbf98838f873d919e |
| institution | DOAJ |
| issn | 2044-6055 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-eb628f56dc5e486fbf98838f873d919e2025-08-20T03:22:07ZengBMJ Publishing GroupBMJ Open2044-60552025-06-0115610.1136/bmjopen-2024-088808Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort studyKevin G Pollock0Bethany Levick1Faisal Sheikh2Baptiste Coxam3Hanna Kew4Maeve Fraser5Chris Rolfe6Tracey Ellison7Bristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, UKHarvey Walsh Limited, Runcorn, UKBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, UKBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, UKBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, UKBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge, UKHarvey Walsh Limited, Runcorn, UKHarvey Walsh Limited, Runcorn, UKObjectives Inflammatory bowel diseases (IBDs) and multiple sclerosis (MS) are inflammatory diseases resulting from an interplay of genetic and environmental factors. This study aims to describe the prevalence of patients diagnosed with both conditions among those receiving hospital care in England, as well as the characteristics and healthcare resource use (HCRU) of such patients.Design This study is a retrospective observational cohort study.Setting The study was conducted through secondary use of the English Hospital Episode Statistics (HES) Database. HES records care delivered by hospitals in England and associated diagnoses.Participants Patients who had a diagnosis code for either IBD or MS recorded in HES between January 2014 and May 2020 were included. Patients were classified as having each diagnosis individually or as having both diagnoses, in which case they were further categorised based on temporal occurrence.Primary and secondary outcome measures The primary outcome was the prevalence of patients with a recorded diagnosis of either IBD, MS or both during the study period. Secondary outcome measures included patient demographic and clinical characteristics, as well as HCRU in the 6 months before and after the diagnosis of interest.Results From an overall cohort of 352 698 patients, 1016 (0.3%) had both diagnoses. Among those with both, 29.8% (303) had a record of IBD first, 40.5% (411) had MS diagnosed first and 29.7% (302) had the first record of both diagnoses in the same episode. From the overall cohort, 80.9% (285 439) of patients had a single diagnosis of IBD, and 18.8% (66 243) of patients had a single diagnosis of MS.Conclusions The population with a dual diagnosis of IBD and MS is larger than previously reported and shows evidence of frequent interactions with secondary care.https://bmjopen.bmj.com/content/15/6/e088808.full |
| spellingShingle | Kevin G Pollock Bethany Levick Faisal Sheikh Baptiste Coxam Hanna Kew Maeve Fraser Chris Rolfe Tracey Ellison Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study BMJ Open |
| title | Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study |
| title_full | Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study |
| title_fullStr | Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study |
| title_full_unstemmed | Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study |
| title_short | Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study |
| title_sort | clinical profile of patients with comorbid ibd and ms and associated service impact in england s secondary care setting a retrospective cohort study |
| url | https://bmjopen.bmj.com/content/15/6/e088808.full |
| work_keys_str_mv | AT kevingpollock clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT bethanylevick clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT faisalsheikh clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT baptistecoxam clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT hannakew clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT maevefraser clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT chrisrolfe clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy AT traceyellison clinicalprofileofpatientswithcomorbidibdandmsandassociatedserviceimpactinenglandssecondarycaresettingaretrospectivecohortstudy |